한국어
English
日本語
中文(简体)Approval withdrawn
Reyataz Capsule 200 mg (Atazanavir Sulfate)
227.79mg
Prescription medication
(Co., Ltd.) HanKook BMS Pharmaceuticals
Atazanavir sulfate is an antiretroviral medication used to treat HIV infections.
MFDS ingredient code M263079
Atazanavir sulfate is an antiviral component belonging to the class of protease inhibitors that suppresses the replication of the HIV virus. This component is used to reduce the viral load in patients with HIV infection and to protect immune function.
Atazanavir blocks the protease enzyme necessary for the HIV virus to replicate, preventing the virus from reproducing properly. As a result, the viral load decreases and the progression of the infection is delayed.
Approved uses differ by product. Check each product's information for its actual use.
Compared to other protease inhibitors, atazanavir is more convenient for dosing and has fewer interactions with certain medications. Additionally, when used with cobicistat, its effectiveness is enhanced, leading to improved therapeutic outcomes.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.